Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis-a study of 106 primary neuroblastomas treated in a single institute

被引：2

作者：

Hishiki, Tomoro ^{[1
]}

Saito, Takeshi ^{[1
]}

Terui, Keita ^{[1
]}

Sato, Yoshiharu ^{[1
]}

Takenouchi, Ayako ^{[1
]}

Yahata, Eriko ^{[1
]}

Ono, Sachie ^{[1
]}

Nakagawara, Akira ^{[2
]}

Kamijo, Takehiko ^{[2
]}

Nakamura, Yohko ^{[2
]}

Matsunaga, Tadashi ^{[1
]}

Yoshida, Hideo ^{[1
]}

机构：

[1] Chiba Univ, Grad Sch Med, Dept Pediat Surg, Chiba 2608677, Japan

[2] Chiba Canc Ctr, Res Inst, Div Biochem & Mol Carcinogenesis, Chiba 2608717, Japan

来源：

JOURNAL OF PEDIATRIC SURGERY | 2010年 / 45卷 / 12期

关键词：

Neuroblastoma; trkA; Quantitative PCR; Real-time PCR; PROTOONCOGENE EXPRESSION; MYCN AMPLIFICATION; NEURO-BLASTOMA; PROGNOSIS; GENES; RET;

D O I：

10.1016/j.jpedsurg.2010.08.021

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Background/Purpose: It has previously been shown that neuroblastomas with favorable prognosis often express a high level of nerve growth factor receptor trkA. We performed an expression analysis of trkA in 106 NB samples based on the quantitative real-time polymerase chain reaction (PCR) and reevaluated the prognostic power of trkA. Materials and methods: A total of 106 primary tumors from NB patients treated from 1988 to 2009 were analyzed. MYCN was amplified in 13 cases. TaqMan probe method was used for quantitative PCR. Primers and probes were designed to detect trkA I and trkA II, but not the oncogenic splice variant trkA III. Results: Expression analysis by real-time PCR revealed a wide range of expression levels of trkA within neuroblastoma tissues. Extremely low levels of trkA that were undetectable by semiquantitative PCR were able to be quantified by this method. trkA was predominantly expressed in tumors with favorable outcome. Further analysis of trkA expression was performed in a cohort excluding mass-screened neuroblastomas. Strikingly, multivariate analysis containing age, MYCN status, and trkA expression identified trkA as the only variable that independently predicts the prognosis of the 44 patients who presented clinically. Conclusion: High-resolution expression analysis targeting trkA and trkA II may add more statistical power on trkA as a biological marker. (C) 2010 Elsevier Inc. All rights reserved.

引用

页码：2293 / 2298

页数：6